It has been well established that device closure has, on average, prevented stroke recurrence in people who’ve had patent foramen ovale–associated stroke, but a meta-analysis has drilled down into ...

Global PFO Closure Device Market Size was estimated at USD 121.53 million in 2021 and is projected to reach USD 208.00 million by 2028, exhibiting a CAGR of 7.98% during the forecast period. “PFO ...

Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "PFO Closure Device Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. In a landscape shaped by evolving ...

- Patent Foramen Ovale (PFO) Closure Devices Market size is expected to rise by 2026 owing to increasing prevalence, escalating preferences for minimally-invasive, safety, technically feasible ...

Percutaneous device occlusion is currently the standard therapeutic option for PFO-related ischemic stroke. However, there are risks associated with implantation of this permanent device, including ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA has approved its patent foramen ovale occlusion system for patients with a PFO and ...

NMT Medical (Boston) said its StarFlex device did not achieve its primary endpoint in the company's CLOSURE I trial for patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in ...

The first-ever guidelines for interventional cardiologists using percutaneous patent foramen ovale closure recommend expanding the use of the procedure beyond the Food and Drug Administration-approved ...

The population of patients undergoing patent foramen ovale (PFO) closure in the US doesn’t match those of the clinical trials that formed the basis of the US Food and Drug Administration’s approval of ...

(MENAFN- GlobeNewsWire - Nasdaq) The PFO closure device market is driven by a shift to minimally invasive solutions and patient-centric care. Opportunities lie in transcatheter methods, bioresorbable ...